Published: Jan 01, 2021, 01:55 IST | Updated: Jan 01, 2021, 01:55 IST
Expert panel at Central Drugs Standard Control Organization has recommended emergency use of Covishield (AstraZeneca) vaccine for coronavirus vaccination in India. The panel has recommended AstraZeneca vaccine with certain conditions. The vaccine is being developed by AstraZeneca and Oxford University. Serum Institute of India (SII) will manufacture the vaccine.